Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Last Crossflo news 4/23/09 (GSA Contract Award)

I see this both ways with OTCBB stocks.

  • Too much news, some consider pumping and hype.
  • Too little news frustrates stock holders.

Ya just can't win....

For me, I prefer less frequent news, but all encompassing when a PR goes out. In other words, many wins written in one big PR, that really catches the attention of potential new investors.

Far too many pink sheet stocks dribble out stuff a few times a month, and I view that as being despirate to change their image.

Just my opinion...

Share
New Message
Please login to post a reply